Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Verizon in Chicago: Becker’s HIT RCM

Healthcare leaders are discovering how reliable connectivity serves as the foundation for solving critical industry challenges like staffing and operational eff

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By Healthcare ·
Share

Key takeaways

01

Healthcare leaders are discovering how reliable connectivity serves as the foundation for solving critical industry challenges like staffing and operational eff

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

In this episode of Healthcare On Air by Verizon, host Robin Goldsmith discusses insights from the Becker's HIT RCM conference in Chicago. The conference served as a platform for healthcare leaders and tech innovators to explore the role of connectivity in addressing healthcare challenges. Key topics included staffing shortages, operational efficiency, and technology adoption. Breakout sessions covered diverse healthcare subjects, and a roundtable discussion offered insights from adjacent industries. Verizon's unwavering commitment to healthcare innovation in the digital age invites professionals to join in and drive transformative change.

Video TranscriptExpand ↓

Hey, everyone, and welcome back to health care on air by Verizon. I'm your host, Robin Goldsmith Global Lead Global Lead for Health Innovation in strategy here at Verizon. So our Verizon healthcare team recently attended the eighth annual Becker's HIT RCM conference in Good Old Chicago where health care leaders and tech innovators from across the country and really across the globe, gather to discuss the latest trends and innovate on solutions together. Our Verizon team hosted an incredible roundtable featuring Scott Lawrence, RSVP of Global Solutions, and Gary Lynch, our global lead for Healthcare Innovation and was moderated by yours truly. With over two dozen senior level health care executives, our dedicated health care team, including Karen Finger, and Netcini discussed the critical role connectivity plays in delivering technology that addresses a whole host of challenges. To name a few staffing shortages, how to streamline operations, how to deliver an ROI when you're looking at adopting technology, and creating a basis for future technology adoption Breakout discussions focused on everything from health equity to hospital room of the future, contact centers, of course, patient experience, the digital front door, cybersecurity, and even a little bit of revenue cycle. And Scott shared critical insights from adjacent industries around tech advances that can be applied to the healthcare vertical. Verizon has committed to ongoing engagement and innovation with health care experts, as well as our partners. As we all move toward the common goal of driving meaningful and an impactful change in health care, We're all going through this digital evolution and health care together. So please come innovate with us.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

H
Healthcare

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

H
Healthcare

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512